<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Petersdorf EW</submitter><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>2524-2531</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6097831</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(24)</volume><pubmed_abstract>Purpose HLA mismatching increases mortality after unrelated donor hematopoietic cell transplantation. The role of the patient's germline variation on survival is not known. Patients and Methods We previously identified 12 single nucleotide polymorphisms within the HLA region as markers of transplantation determinants and tested these in an independent cohort of 1,555 HLA-mismatched unrelated transplants. Linkage disequilibrium mapping across class II identified candidate susceptibility features. The candidate gene was confirmed in an independent cohort of 3,061 patients. Results Patient rs429916AA/AC was associated with increased transplantation-related mortality compared with rs429916CC (hazard ratio [HR], 1.39; 95% CI, 1.12 to 1.73; P = .003); rs429916A positivity was a proxy for DOA*01:</pubmed_abstract><journal>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</journal><pubmed_title>Patient HLA Germline Variation and Transplant Survivorship.</pubmed_title><pmcid>PMC6097831</pmcid><funding_grant_id>R01 CA100019</funding_grant_id><funding_grant_id>U01 AI069197</funding_grant_id><funding_grant_id>P01 CA018029</funding_grant_id><funding_grant_id>U24 CA076518</funding_grant_id><funding_grant_id>R01 AI121242</funding_grant_id><funding_grant_id>U01 CA162194</funding_grant_id><funding_grant_id>U01 HL069294</funding_grant_id><pubmed_authors>Strong RK</pubmed_authors><pubmed_authors>Malkki M</pubmed_authors><pubmed_authors>Haagenson MD</pubmed_authors><pubmed_authors>Horowitz MM</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Petersdorf EW</pubmed_authors><pubmed_authors>Stevenson P</pubmed_authors><pubmed_authors>Spellman SR</pubmed_authors><pubmed_authors>Gooley T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient HLA Germline Variation and Transplant Survivorship.</name><description>Purpose HLA mismatching increases mortality after unrelated donor hematopoietic cell transplantation. The role of the patient's germline variation on survival is not known. Patients and Methods We previously identified 12 single nucleotide polymorphisms within the HLA region as markers of transplantation determinants and tested these in an independent cohort of 1,555 HLA-mismatched unrelated transplants. Linkage disequilibrium mapping across class II identified candidate susceptibility features. The candidate gene was confirmed in an independent cohort of 3,061 patients. Results Patient rs429916AA/AC was associated with increased transplantation-related mortality compared with rs429916CC (hazard ratio [HR], 1.39; 95% CI, 1.12 to 1.73; P = .003); rs429916A positivity was a proxy for DOA*01:</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Aug</publication><modification>2025-04-19T04:38:26.737Z</modification><creation>2019-08-23T07:00:22Z</creation></dates><accession>S-EPMC6097831</accession><cross_references><pubmed>29902106</pubmed><doi>10.1200/JCO.2017.77.6534</doi><doi>10.1200/jco.2017.77.6534</doi></cross_references></HashMap>